Exchange: NASDAQ·Updated 07:30 PM EDT
XFOR logo

XFOR X4 Pharmaceuticals Inc

$4.16
$0.11
(2.72%)
Today
Closed $4.16
$0.00
(0.00%)
After Hours
Reported EarningsAug 6
Mkt Cap$401.54M
Vol390,755.00

About XFOR

X4 Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. It is focused on mavorixafor which is being marketed in the U.S. under the trade name xolremdi. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA.
49

Neutral Sentiment

How do you feel about XFOR?

Advertisement|Remove ads.